Constantly, a marked decrease in blood vessels expressing CD31-positive cells (Fig. 5a) and a significant suppression of vascular density (Fig. 5d) was also observed in the tumor tissues of animals received Ad-ΔB/TRAIL+Ad-ΔB/IL-12 combination therapy than other treated groups. This evidence concerns the gene TNFSF10 and neoplasm.